Pyruvate

Pyruvate

SCHEMBL4659826

CC(=O)C(=O)O.NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADH1A P07327 2/20 0.92
▸ LMNA P02545 1/20 0.70
▸ PMP22 Q01453 1/20 0.70
▸ TP53 P04637 1/20 0.70
▸ TSHR P16473 1/20 0.70
▸ ALOX12 P18054 1/20 0.70
▸ P2RY1 P47900 6/20 0.67
▸ P2RY2 P41231 2/20 0.67
▸ SRC P12931 1/20 0.67
▸ P2RX1 P51575 1/20 0.67
▸ P2RX3 P56373 1/20 0.67
▸ P2RX4 Q99571 1/20 0.67
▸ P2RX2 Q9UBL9 1/20 0.67
▸ ALDH1A1 P00352 1/20 0.67
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ LDHA P00338 1/20 0.67
▸ LDHB P07195 1/20 0.67
▸ MACROD2 A1Z1Q3 1/20 0.64
▸ SIRT6 Q8N6T7 1/20 0.64
▸ MACROD1 Q9BQ69 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7996774 0.97 ADH1A (0.94) ADH1ALMNAPMP22TP53TSHR
Oxalic Acid SCHEMBL8974842 0.96 ADH1A (0.96) ADH1ALMNAPMP22TP53TSHR
Hydrogen Peroxide SCHEMBL9681552 0.96 ADH1A (0.98) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29740660 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL8003782 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29350404 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL8187 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL20202727 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL1276381 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR
SCHEMBL29351291 0.96 ADH1A (1.00) ADH1ALMNAPMP22TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50715-E1 Synthetic biochemistry molecular purge valve module that maintain co-factor balance THE REGENTS OF THE UNIVESITY OF CALIFORNIA (US) 2025-12-30 — — US claimed
US-RE50715-E1 Synthetic biochemistry molecular purge valve module that maintain co-factor balance THE REGENTS OF THE UNIVESITY OF CALIFORNIA (US) 2025-12-30 — — US disclosed
CN-108949652-B Engineering bacterium and application thereof in producing caffeic acid 江南大学 2022-08-09 — — CN disclosed
CN-108949840-B Engineering bacterium and application thereof in production of p-hydroxycinnamic acid 江南大学 2021-10-19 — — CN disclosed
CN-108949656-B Engineering bacterium and application thereof in production of pyruvic acid 江南大学 2021-03-26 — — CN disclosed
CN-108949649-B Engineering bacterium and application thereof in producing levodopa 江南大学 2021-03-26 — — CN disclosed
CN-108949647-B Engineering bacterium and application thereof in production of L-tyrosine 江南大学 2020-12-29 — — CN disclosed
EP-2535717-A1 Method for determining the mortality risk Universitätsklinikum Hamburg-Eppendorf (DE) 2012-12-19 — — EP disclosed
EP-1304955-B1 USE OF ULTRAVIOLET, NEAR-ULTRAVIOLET AND NEAR INFRARED RESONANCE RAMAN SPECTROSCOPY AND FLUORESCENCE SPECTROSCOPY FOR TISSUE INTERROGATION OF SHOCK STATES, CRITICAL ILLNESSES, AND OTHER DISEASE STATES UNIV VIRGINIA COMMONWEALTH (US) 2008-12-17 — — EP disclosed
US-7113814-B2 Tissue interrogation spectroscopy VIRGINIA COMMONWEALTH UNIVERSITY (US) 2006-09-26 — — US disclosed
EP-1304955-A4 USE OF ULTRAVIOLET, NEAR-ULTRAVIOLET AND NEAR INFRARED RESONANCE RAMAN SPECTROSCOPY AND FLUORESCENCE SPECTROSCOPY FOR TISSUE INTERROGATION OF SHOCK STATES, CRITICAL ILLNESSES, AND OTHER DISEASE STATES UNIV VIRGINIA COMMONWEALTH (US) 2005-09-28 — — EP disclosed
US-20040039269-A1 Use of ultraviolet, near-ultraviolet and near infrared resonance raman spec-troscopy and fluorescence spectroscopy fro tissue interrogation of shock states, critical illnesses, and other disease states NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-02-26 — — US disclosed
EP-1304955-A2 USE OF ULTRAVIOLET, NEAR-ULTRAVIOLET AND NEAR INFRARED RESONANCE RAMAN SPECTROSCOPY AND FLUORESCENCE SPECTROSCOPY FOR TISSUE INTERROGATION OF SHOCK STATES, CRITICAL ILLNESSES, AND OTHER DISEASE STATES VIRGINIA COMMONWEALTH UNIVERSITY (US) 2003-05-02 — — EP disclosed
WO-2002007585-A2 TISSUE INTERROGATION SPECTROSCOPY VIRGINIA COMMONWEALTH UNIVERSITY (US) 2002-01-31 — — WO disclosed
US-5985617-A FORMING 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE TEXAS A & M UNIVERSITY SYSTEM, THE 1999-11-16 — — US disclosed
EP-0736103-A4 NUCLEOTIDE-DIRECTED ASSEMBLY OF BIMOLECULAR AND MULTIMOLECULAR DRUGS AND DEVICES CUBICCIOTTI ROGER S (US) 1999-07-28 — — EP disclosed
EP-0736103-A1 NUCLEOTIDE-DIRECTED ASSEMBLY OF BIMOLECULAR AND MULTIMOLECULAR DRUGS AND DEVICES Cubicciotti, Roger S. (US) 1996-10-09 — — EP disclosed
WO-1995016788-A1 NUCLEOTIDE-DIRECTED ASSEMBLY OF BIMOLECULAR AND MULTIMOLECULAR DRUGS AND DEVICES CUBICCIOTTI ROGER S (US) 1995-06-22 — — WO disclosed
US-5200325-A Mixing Sample Containing Glucose with NAD and Glucose Dehydrog enase to Form NADH, Adding Pyruvate and Lactate Dehydrogenase to Convert NADH to NAD and Pyruvate to Lactate and Determining if any NADH Remains by Measuring Light Absorption MILES INC. (US) 1993-04-06 — — US disclosed
WO-1991005063-A1 HALOPEROXIDASE ACID OPTIMUM CHEMILUMINESCENCE ASSAY SYSTEM EXOXEMIS, INC. (US) 1991-04-18 — — WO disclosed
Send feedback